Skip to main content
Signal8

LifeMD, Inc. (LFMD) Form 8-K — Nov 12, 2026

$LFMDForm 8-KItems 1.01, 2.02, 2.03, 3.02, 7.01, 9.01Filed Nov 12, 2026, 4:10 PM ET0001493152-26-051397Original filing

LifeMD closed a $12.5 million secured term loan on November 9, 2026 with Avenue Venture Opportunities Fund II and Avenue Growth Lending Fund III, secured by substantially all of the borrower subsidiaries' assets. The loan accrues interest at the greater of Prime + 4.50% or 11.50%, is interest-only for up to 24 months, and matures May 1, 2030. In connection with the financing, LifeMD issued lenders warrants for $625,000 of common stock at $2.32 per share (about 269,376 shares) and paid a $125,000 commitment fee. The closing required termination of the company's Citizens Bank credit facility, which had no amounts outstanding.

Key figures

Debt Amount
12500000
Interest Rate
greater of Prime Rate + 4.50% or 11.50% per annum
Maturity Date
May 1, 2030
Commitment fee
125000
Prepayment penalty
1.00% to 3.00%
Interest only period
up to 24 months
Revenue covenant ttm
$150 million minimum trailing twelve-month net revenue beginning with fiscal quarter ending December 31, 2026
Final payment percent
3.50% of original principal
Commitment fee percent
1.00%
Warrant underlying shares
269376
Warrants purchased amount
$625,000 in common stock
Warrant stock purchase price
$2.32 per share

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.